Stay updated with breaking news from Presentation Time. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The preliminary results from the phase 2 study investigating AFM24 in combination with the checkpoint inhibitor atezolizumab in patients with EGFR wild-type non-small cell lung cancer have been...
Addition of Affimed’s innate cell engager improves cytotoxicity of natural killer cells and CAR-NK cellsNK cells with ICE® show at least comparable anti-tumor cell efficacy to CAR-NK cells with...
/PRNewswire/ -- South Rampart Pharma, Inc. ("South Rampart" or the "Company"), a clinical-stage life science company developing SRP-001, a first-in-class...
SEATTLE, Sept. 22, 2023 -- Rover Group, Inc. , the world’s largest online marketplace for pet care, today announced that management will present at the following investor conference: Jefferies...
SEATTLE, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Rover Group, Inc. (NASDAQ:ROVR) ("Rover" or the "Company"), the world's largest online marketplace for pet care, today announced that management will present at the following